title: Lentiviral-mediated gene transfer to the sheep brain: implications for gene therapy in Batten disease.
abstract: The neuronal ceroid lipofuscinoses (NCLs; Batten disease) are inherited neurodegenerative lysosomal storage diseases with common clinical features of blindness and seizures culminating in premature death. Gene-therapy strategies for these diseases depend on whether the missing activity is a secreted lysosomal protein taken up by neighboring cells, or an intramembrane protein that requires careful targeting. Therapies are best developed in animal models with large complex human-like brains. Lentiviral-mediated gene delivery to neural cell cultures from normal sheep and sheep affected with an NCL resulted in green fluorescent protein (GFP) expression in neurons and neuroblasts, more efficiently than in astrocytes. Similar transgene expression was obtained from two constitutive promoters, the viral MND promoter and the human EF1α promoter. In vivo studies showed stable and persistent GFP expression throughout the cell bodies, axons, and dendrites from intracortical injections and indicated ependymal and subependymal transduction. The sheep showed no ill effects from the injections. These data support continuing gene-therapy trials in the sheep models of Batten disease.
authors: Department of Biochemistry, School of Medical Sciences, University of Otago, Dunedin 9054, New Zealand.
authors: Kathryn S
authors: KS
authors: Linterman
authors: David N
authors: DN
authors: Palmer
authors: Graham W
authors: GW
authors: Kay
authors: Lucy A
authors: LA
authors: Barry
authors: Nadia L
authors: NL
authors: Mitchell
authors: Robin G
authors: RG
authors: McFarlane
authors: Michael A
authors: MA
authors: Black
authors: Mark S
authors: MS
authors: Sands
authors: Stephanie M
authors: SM
authors: Hughes
references: Sci Transl Med. 2010 Apr 21;2(28):28ra28
references: 20410529
references: J Gene Med. 2006 Apr;8(4):414-24
references: 16389638
references: J Neurosci Methods. 2008 May 15;170(1):56-66
references: 18276015
references: Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11619-24
references: 10500226
references: Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):9023-7
references: 12853570
references: Exp Cell Res. 2004 Aug 15;298(2):399-406
references: 15265688
references: Cell. 1999 Jan 8;96(1):25-34
references: 9989494
references: Cell. 1999 Jun 11;97(6):703-16
references: 10380923
references: ILAR J. 2009;50(2):112-21
references: 19293456
references: J Biol Chem. 2004 May 21;279(21):21883-7
references: 15010464
references: Gene Ther. 2003 Jan;10(1):34-42
references: 12525835
references: J Gene Med. 2009 Jun;11(6):498-505
references: 19338016
references: Am J Hum Genet. 2002 Feb;70(2):537-42
references: 11727201
references: Mol Genet Metab. 2010 Dec;101(4):357-63
references: 20817517
references: Biochim Biophys Acta. 2006 Oct;1762(10):898-905
references: 17046213
references: Mol Ther. 2007 Mar;15(3):481-91
references: 17180118
references: Neurosci Res. 2007 Apr;57(4):550-8
references: 17275114
references: Neurobiol Dis. 2004 Jul;16(2):360-9
references: 15193292
references: Am J Hum Genet. 2002 Feb;70(2):324-35
references: 11791207
references: Science. 1992 Mar 27;255(5052):1707-10
references: 1553558
references: N Z Vet J. 2002 Oct;50(5):199-202
references: 16032271
references: J Neurosci Res. 2003 Sep 15;73(6):876-85
references: 12949915
references: Hum Mol Genet. 2010 May 15;19(10):1873-82
references: 20154343
references: J Biol Chem. 2004 May 21;279(21):22347-52
references: 15010453
references: Mol Cell Proteomics. 2006 Oct;5(10):1942-56
references: 16709564
references: In Vitro Cell Dev Biol Anim. 2008 Nov-Dec;44(10):397-406
references: 18810562
references: J Neurosci Methods. 2006 Jul 15;155(1):98-108
references: 16487596
references: Hum Gene Ther. 2010 Sep;21(9):1093-103
references: 20408734
references: Mol Ther. 2006 Mar;13(3):538-47
references: 16364693
references: Nat Neurosci. 2000 Nov;3(11):1091-7
references: 11036265
references: Neurobiol Dis. 2004 Jun;16(1):29-40
references: 15207259
references: Mol Ther. 2001 Aug;4(2):149-56
references: 11482987
references: Nat Med. 1998 Nov;4(11):1313-7
references: 9809557
references: Exp Neurol. 2008 Sep;213(1):18-27
references: 18639872
references: Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13883-8
references: 11095732
references: Neurobiol Dis. 2008 Feb;29(2):306-15
references: 17988881
references: Proteomics. 2005 Apr;5(6):1520-32
references: 15789345
references: Neurobiol Dis. 2005 Oct;20(1):49-63
references: 16137566
references: Stem Cells. 2008 Jul;26(7):1713-22
references: 18436861
references: Mol Genet Metab. 2004 Sep-Oct;83(1-2):163-74
references: 15464431
references: Hum Gene Ther. 2008 May;19(5):463-74
references: 18473686
references: Am J Med Genet Suppl. 1988;5:21-6
references: 3146319
references: J Virol. 1998 Dec;72(12):9873-80
references: 9811723
references: Neuropharmacology. 2008 Aug;55(2):166-74
references: 18572205
references: Mol Ther. 2005 May;11(5):776-89
references: 15851016
references: Mol Ther. 2001 Apr;3(4):565-73
references: 11319919
references: Mol Ther. 2005 Sep;12(3):413-21
references: 15979943
references: Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6216-21
references: 11959904
references: J Neurosci. 1999 Jun 1;19(11):4462-71
references: 10341247
references: J Virol. 1995 Feb;69(2):748-55
references: 7815539
references: Mol Ther. 2002 May;5(5 Pt 1):528-37
references: 11991743